Cervomed Stock Analysis
| CRVO Stock | 7.25 0.16 2.16% |
CervoMed is undervalued with Real Value of 11.0 and Target Price of 22.43. The main objective of CervoMed stock analysis is to determine its intrinsic value, which is an estimate of what CervoMed is worth, separate from its market price. There are two main types of CervoMed's stock analysis: fundamental analysis and technical analysis.
The CervoMed stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. CervoMed is usually not traded on Memorial Day, Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday. CervoMed Stock trading window is adjusted to America/New York timezone.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CervoMed. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. CervoMed Stock Analysis Notes
About 31.0% of the company shares are held by company insiders. The book value of CervoMed was currently reported as 2.81. The company recorded a loss per share of 2.9. CervoMed last dividend was issued on the 14th of December 2018. The entity had 2:3 split on the 17th of August 2023. For more info on CervoMed please contact John MD at 617 744 4400 or go to https://www.cervomed.com.CervoMed Investment Alerts
| CervoMed generated a negative expected return over the last 90 days | |
| CervoMed has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 9.74 M. Net Loss for the year was (16.29 M) with loss before overhead, payroll, taxes, and interest of (926.81 K). | |
| CervoMed generates negative cash flow from operations | |
| CervoMed has a poor financial position based on the latest SEC disclosures | |
| About 31.0% of the company shares are held by company insiders | |
| Latest headline from thelincolnianonline.com: HC Wainwright Issues Negative Forecast for CervoMed Earnings |
CervoMed Upcoming and Recent Events
Earnings reports are used by CervoMed to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period..
| 12th of February 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 12th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
CervoMed Largest EPS Surprises
Earnings surprises can significantly impact CervoMed's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-08-09 | 2024-06-30 | -0.31 | -0.27 | 0.04 | 12 | ||
2025-06-13 | 2025-03-31 | -0.6233 | -0.56 | 0.0633 | 10 | ||
2024-03-29 | 2023-12-31 | -0.29 | -0.38 | -0.09 | 31 |
CervoMed Environmental, Social, and Governance (ESG) Scores
CervoMed's ESG score is a quantitative measure that evaluates CervoMed's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of CervoMed's operations that may have significant financial implications and affect CervoMed's stock price as well as guide investors towards more socially responsible investments.
CervoMed Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 68.52 M.CervoMed Profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.38) | (0.40) | |
| Return On Capital Employed | (0.46) | (0.49) | |
| Return On Assets | (0.38) | (0.40) | |
| Return On Equity | (0.42) | (0.44) |
Management Efficiency
CervoMed has return on total asset (ROA) of (0.4278) % which means that it has lost $0.4278 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.7142) %, meaning that it created substantial loss on money invested by shareholders. CervoMed's management efficiency ratios could be used to measure how well CervoMed manages its routine affairs as well as how well it operates its assets and liabilities. As of the 13th of November 2025, Return On Tangible Assets is likely to drop to -0.4. In addition to that, Return On Capital Employed is likely to drop to -0.49. At this time, CervoMed's Asset Turnover is very stable compared to the past year.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 4.86 | 5.10 | |
| Tangible Book Value Per Share | 4.86 | 5.10 | |
| Enterprise Value Over EBITDA | (0.54) | (0.57) | |
| Price Book Value Ratio | 0.48 | 0.46 | |
| Enterprise Value Multiple | (0.54) | (0.57) | |
| Price Fair Value | 0.48 | 0.46 | |
| Enterprise Value | 14.1 M | 13.4 M |
The leadership approach at CervoMed's fosters a culture of excellence and accountability. Our analysis examines how this culture influences financial outcomes and stock valuation.
Technical Drivers
As of the 13th of November 2025, CervoMed shows the Standard Deviation of 3.55, risk adjusted performance of (0.04), and Mean Deviation of 2.84. CervoMed technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.CervoMed Price Movement Analysis
java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Triple Exponential Moving Average (T3) indicator is developed by Tim Tillson as CervoMed price series composite of a single exponential moving average, a double exponential moving average and a triple exponential moving average.
CervoMed Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific CervoMed insiders, such as employees or executives, is commonly permitted as long as it does not rely on CervoMed's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases CervoMed insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
CervoMed Outstanding Bonds
CervoMed issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. CervoMed uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most CervoMed bonds can be classified according to their maturity, which is the date when CervoMed has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
CervoMed Predictive Daily Indicators
CervoMed intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of CervoMed stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 6077.22 | |||
| Daily Balance Of Power | (0.29) | |||
| Rate Of Daily Change | 0.98 | |||
| Day Median Price | 7.52 | |||
| Day Typical Price | 7.43 | |||
| Price Action Indicator | (0.35) | |||
| Period Momentum Indicator | (0.16) |
CervoMed Corporate Filings
8K | 10th of November 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
10Q | 7th of November 2025 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
8K | 4th of November 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
8K | 29th of October 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
8K | 22nd of October 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F3 | 8th of October 2025 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
| 20th of August 2025 Other Reports | ViewVerify | |
| 14th of August 2025 Other Reports | ViewVerify |
CervoMed Forecast Models
CervoMed's time-series forecasting models are one of many CervoMed's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary CervoMed's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About CervoMed Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how CervoMed prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling CervoMed shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as CervoMed. By using and applying CervoMed Stock analysis, traders can create a robust methodology for identifying CervoMed entry and exit points for their positions.
| Last Reported | Projected for Next Year | ||
| Pretax Profit Margin | (1.67) | (1.76) | |
| Operating Profit Margin | (1.87) | (1.97) | |
| Net Loss | (1.67) | (1.76) | |
| Gross Profit Margin | (0.93) | (0.98) |
Current CervoMed Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. CervoMed analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. CervoMed analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
| Target Price | Advice | # of Analysts | |
| 22.43 | Strong Buy | 7 | Odds |
Most CervoMed analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand CervoMed stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of CervoMed, talking to its executives and customers, or listening to CervoMed conference calls.
CervoMed Stock Analysis Indicators
CervoMed stock analysis indicators help investors evaluate how CervoMed stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading CervoMed shares will generate the highest return on investment. By understating and applying CervoMed stock analysis, traders can identify CervoMed position entry and exit signals to maximize returns.
| Begin Period Cash Flow | 7.8 M | |
| Common Stock Shares Outstanding | 8.1 M | |
| Total Stockholder Equity | 39.2 M | |
| Total Cashflows From Investing Activities | -28.7 M | |
| Cash And Short Term Investments | 38.9 M | |
| Cash | 9 M | |
| Accounts Payable | 1.5 M | |
| Net Debt | -9 M | |
| 50 Day M A | 8.0602 | |
| Total Current Liabilities | 3.9 M | |
| Other Operating Expenses | 18.2 M | |
| Non Currrent Assets Other | -373.9 K | |
| Stock Based Compensation | 1.4 M |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CervoMed. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. To learn how to invest in CervoMed Stock, please use our How to Invest in CervoMed guide.You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CervoMed. If investors know CervoMed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CervoMed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.90) | Revenue Per Share | Quarterly Revenue Growth (0.83) | Return On Assets | Return On Equity |
The market value of CervoMed is measured differently than its book value, which is the value of CervoMed that is recorded on the company's balance sheet. Investors also form their own opinion of CervoMed's value that differs from its market value or its book value, called intrinsic value, which is CervoMed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CervoMed's market value can be influenced by many factors that don't directly affect CervoMed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CervoMed's value and its price as these two are different measures arrived at by different means. Investors typically determine if CervoMed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CervoMed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.